Premium
BetterLife Pharma Inc (QB) (BETRF)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | Dr. Ahmad DoroudianFounder, CEO & Director | 200,00k | 11,00k | Achat | 0,05 - 0,06 | 16,78M | 1,21% |
| 2026-06-15 | Dr. Hooshmand SheshbaradaranCOO | 1,75M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 4,35M | 67,31% |
| 2026-06-15 | Ms. Moira OngCFO | 500,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,10M | 31,25% |
| 2026-06-19 | Mr. Douglas L. DrysdaleExecutive Chairman & Member of Scientific Advisory Board | 100,00k | 0,00 | Achat | - | 1,61M | 6,63% |
| 2026-06-15 | Dr. Ahmad DoroudianFounder, CEO & Director | 1 000,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 3,10M | 47,62% |
| 2026-06-19 | Dr. Stephen SanghaCorporate Development Advisor & Director | -200,00k | 0,00 | Other Derivative Disposition | - | 1,15M | -14,81% |
| 2026-06-13 | Dr. Ahmad DoroudianFounder, CEO & Director | -500,00k | 0,00 | Other Derivative Disposition | - | 5,26M | -8,68% |
| 2026-06-13 | Dr. Stephen SanghaCorporate Development Advisor & Director | -1 000,00k | 0,00 | Other Derivative Disposition | - | 3,03M | -24,79% |
| 2026-06-05 | Dr. Stephen SanghaCorporate Development Advisor & Director | 52,00k | 2,24k | Achat | 0,04 | 25,51M | 0,20% |
| 2026-06-04 | Dr. Stephen SanghaCorporate Development Advisor & Director | 229,00k | 9,88k | Achat | 0,04 | 25,46M | 0,91% |
| 2026-06-01 | Dr. Stephen SanghaCorporate Development Advisor & Director | 242,00k | 10,50k | Achat | 0,04 | 25,23M | 0,97% |
| 2026-05-29 | Dr. Stephen SanghaCorporate Development Advisor & Director | 126,00k | 5,48k | Achat | 0,04 | 25,11M | 0,50% |
| 2026-05-27 | Dr. Stephen SanghaCorporate Development Advisor & Director | 129,00k | 5,61k | Achat | 0,04 | 24,98M | 0,52% |
| 2026-05-27 | Dr. Stephen SanghaCorporate Development Advisor & Director | 327,00k | 14,18k | Achat | 0,04 | 24,86M | 1,33% |
| 2026-05-26 | Dr. Stephen SanghaCorporate Development Advisor & Director | 15,00k | 651,69 | Achat | 0,04 | 24,53M | 0,06% |
| 2026-05-25 | Dr. Stephen SanghaCorporate Development Advisor & Director | -4,22M | 183,54k | Vente | 0,04 | 24,51M | -14,69% |
| 2026-05-25 | Dr. Stephen SanghaCorporate Development Advisor & Director | 3,99M | 173,59k | Achat | 0,04 | 24,51M | 19,46% |
| 2026-05-22 | Dr. Stephen SanghaCorporate Development Advisor & Director | 81,00k | 3,52k | Achat | 0,04 | 24,51M | 0,33% |
| 2026-05-06 | Mr. Ralph Anthony PullenIndependent Director | -50,00k | 2,20k | Vente | 0,04 | 184,67k | -21,31% |
| 2026-05-05 | Mr. Ralph Anthony PullenIndependent Director | -130,00k | 6,14k | Vente | 0,04 - 0,05 | 234,67k | -35,65% |
| 2026-05-07 | Dr. Stephen SanghaCorporate Development Advisor & Director | 281,00k | 12,36k | Achat | 0,04 | 24,66M | 1,15% |
| 2026-05-01 | Dr. Ahmad DoroudianFounder, CEO & Director | -1,79M | 0,00 | Other Derivative Disposition | - | 2,10M | -45,96% |
| 2026-05-01 | Ms. Moira OngCFO | -1,07M | 0,00 | Other Derivative Disposition | - | 1,60M | -40,11% |
| 2026-05-01 | Dr. Hooshmand SheshbaradaranCOO | -2,74M | 0,00 | Other Derivative Disposition | - | 2,60M | -51,29% |
| 2026-04-16 | Dr. Ahmad DoroudianFounder, CEO & Director | 1,25M | 0,00 | Achat | - | 16,68M | 8,10% |
| 2026-04-27 | Dr. Stephen SanghaCorporate Development Advisor & Director | 259,00k | 11,41k | Achat | 0,04 | 24,38M | 1,07% |
| 2026-04-20 | Mr. Ralph Anthony PullenIndependent Director | -70,00k | 3,15k | Vente | 0,04 - 0,05 | 364,67k | -16,10% |
| 2026-04-24 | Dr. Stephen SanghaCorporate Development Advisor & Director | 126,00k | 5,53k | Achat | 0,04 | 24,12M | 0,53% |
| 2026-04-17 | Dr. Stephen SanghaCorporate Development Advisor & Director | 166,00k | 7,29k | Achat | 0,04 | 23,99M | 0,70% |
| 2026-04-17 | Dr. Stephen SanghaCorporate Development Advisor & Director | 216,00k | 9,48k | Achat | 0,04 | 23,83M | 0,91% |
| 2026-04-10 | Dr. Stephen SanghaCorporate Development Advisor & Director | 2,00k | 86,79 | Achat | 0,04 | 23,61M | 0,01% |
| 2026-04-08 | Dr. Stephen SanghaCorporate Development Advisor & Director | 96,00k | 4,16k | Achat | 0,04 | 23,61M | 0,41% |
| 2026-03-31 | Dr. Stephen SanghaCorporate Development Advisor & Director | 26,00k | 1,12k | Achat | 0,04 | 23,51M | 0,11% |
| 2026-03-09 | Dr. Ahmad DoroudianFounder, CEO & Director | 60,00k | 3,10k | Achat | 0,05 | 15,43M | 0,39% |
| 2026-03-09 | Dr. Stephen SanghaCorporate Development Advisor & Director | 61,00k | 2,92k | Achat | 0,05 | 23,49M | 0,26% |
| 2026-02-26 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 4,39k | Achat | 0,04 | 23,43M | 0,43% |
| 2026-02-25 | Dr. Stephen SanghaCorporate Development Advisor & Director | 93,50k | 4,02k | Achat | 0,04 | 23,33M | 0,40% |
| 2026-02-18 | Dr. Ahmad DoroudianFounder, CEO & Director | 1,70M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 3,89M | 77,77% |
| 2026-02-18 | Ms. Moira OngCFO | 1,20M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,67M | 81,55% |
| 2026-02-18 | Dr. Hooshmand SheshbaradaranCOO | 2,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 5,34M | 59,93% |
| 2026-02-18 | Mr. Ralph Anthony PullenIndependent Director | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 450,00k | 350,00% |
| 2026-02-18 | Dr. Stephen SanghaCorporate Development Advisor & Director | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,35M | 35,00% |
| 2026-02-06 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 4,40k | Achat | 0,04 | 23,23M | 0,43% |
| 2026-02-02 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 4,02k | Achat | 0,04 | 23,13M | 0,43% |
| 2026-01-29 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 4,06k | Achat | 0,04 | 23,03M | 0,44% |
| 2026-01-27 | Dr. Stephen SanghaCorporate Development Advisor & Director | 200,00k | 7,35k | Achat | 0,04 | 22,93M | 0,88% |
| 2026-01-23 | Dr. Stephen SanghaCorporate Development Advisor & Director | 200,00k | 7,28k | Achat | 0,04 | 22,73M | 0,89% |
| 2026-01-15 | Dr. Stephen SanghaCorporate Development Advisor & Director | 200,00k | 7,20k | Achat | 0,04 | 22,53M | 0,90% |
| 2026-01-12 | Dr. Wolfgang RenzInitié | -100,00k | 0,00 | Other Derivative Disposition | - | 100,00k | -50,00% |
| 2026-01-12 | Dr. Ahmad DoroudianFounder, CEO & Director | -400,00k | 0,00 | Other Derivative Disposition | - | 2,19M | -15,47% |
| 2026-01-12 | Ms. Moira OngCFO | -400,00k | 0,00 | Other Derivative Disposition | - | 1,47M | -21,37% |
| 2026-01-12 | Dr. Hooshmand SheshbaradaranCOO | -400,00k | 0,00 | Other Derivative Disposition | - | 3,34M | -10,70% |
| 2026-01-12 | Mr. Ralph Anthony PullenIndependent Director | -100,00k | 0,00 | Other Derivative Disposition | - | 100,00k | -50,00% |
| 2026-01-08 | Dr. Stephen SanghaCorporate Development Advisor & Director | 160,00k | 5,77k | Achat | 0,04 | 22,33M | 0,72% |
| 2025-12-31 | Dr. Ahmad DoroudianFounder, CEO & Director | -1,26M | 0,00 | Other Derivative Disposition | - | 4,51M | -21,84% |
| 2025-12-31 | Dr. Stephen SanghaCorporate Development Advisor & Director | -1,04M | 0,00 | Other Derivative Disposition | - | 4,03M | -20,42% |
| 2025-12-23 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 3,28k | Achat | 0,03 | 22,17M | 0,45% |
| 2025-12-16 | Dr. Ahmad DoroudianFounder, CEO & Director | 19,00k | 687,77 | Achat | 0,04 | 15,37M | 0,12% |
| 2025-12-14 | Dr. Ahmad DoroudianFounder, CEO & Director | -1 000,00k | 0,00 | Other Derivative Disposition | - | 5,77M | -14,78% |
| 2025-12-14 | Dr. Stephen SanghaCorporate Development Advisor & Director | -1 000,00k | 0,00 | Other Derivative Disposition | - | 5,07M | -16,48% |
| 2025-12-02 | Dr. Stephen SanghaCorporate Development Advisor & Director | -14,00k | 0,00 | Other Derivative Disposition | - | 6,07M | -0,23% |
| 2025-11-25 | Dr. Ahmad DoroudianFounder, CEO & Director | 12,00k | 525,60 | Achat | 0,04 | 15,35M | 0,08% |
| 2025-11-20 | Dr. Ahmad DoroudianFounder, CEO & Director | 15,00k | 532,83 | Achat | 0,04 | 15,34M | 0,10% |
| 2025-10-23 | Dr. Ahmad DoroudianFounder, CEO & Director | 20,00k | 857,50 | Achat | 0,04 | 15,32M | 0,13% |
| 2025-10-16 | Dr. Ahmad DoroudianFounder, CEO & Director | 20,00k | 854,32 | Achat | 0,04 | 15,30M | 0,13% |
| 2025-10-03 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 5,02k | Achat | 0,05 | 22,07M | 0,46% |
| 2025-10-01 | Mr. Andre BeaudryInitié | 100,00k | 5,31k | Achat | 0,05 | 567,39k | 21,40% |
| 2025-10-01 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 5,02k | Achat | 0,05 | 21,97M | 0,46% |
| 2025-09-29 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 5,39k | Achat | 0,05 | 21,87M | 0,46% |
| 2025-09-29 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 5,39k | Achat | 0,05 | 21,87M | 0,46% |
| 2025-09-25 | Dr. Stephen SanghaCorporate Development Advisor & Director | 100,00k | 5,38k | Achat | 0,05 | 21,67M | 0,46% |
| 2025-09-24 | Dr. Stephen SanghaCorporate Development Advisor & Director | 150,00k | 8,64k | Achat | 0,06 | 21,57M | 0,70% |
| 2025-09-17 | Dr. Stephen SanghaCorporate Development Advisor & Director | 29,00k | 1,79k | Achat | 0,06 | 21,42M | 0,14% |
| 2025-09-17 | Dr. Stephen SanghaCorporate Development Advisor & Director | 41,00k | 2,53k | Achat | 0,06 | 21,42M | 0,19% |
| 2025-09-15 | Dr. Stephen SanghaCorporate Development Advisor & Director | 19,00k | 1,17k | Achat | 0,06 | 21,35M | 0,09% |
| 2025-09-12 | Dr. Stephen SanghaCorporate Development Advisor & Director | 50,00k | 3,07k | Achat | 0,06 | 21,33M | 0,23% |
| 2025-09-12 | Dr. Stephen SanghaCorporate Development Advisor & Director | 26,00k | 1,59k | Achat | 0,06 | 21,33M | 0,12% |
| 2025-09-11 | Dr. Stephen SanghaCorporate Development Advisor & Director | 24,00k | 1,47k | Achat | 0,06 | 21,26M | 0,11% |
| 2025-08-27 | Dr. Stephen SanghaCorporate Development Advisor & Director | 30,00k | 1,84k | Achat | 0,06 | 21,23M | 0,14% |
| 2025-08-26 | Dr. Stephen SanghaCorporate Development Advisor & Director | 2,00k | 122,95 | Achat | 0,06 | 21,20M | 0,01% |
| 2025-08-20 | Dr. Stephen SanghaCorporate Development Advisor & Director | 50,00k | 3,07k | Achat | 0,06 | 21,20M | 0,24% |
| 2025-08-12 | Dr. Stephen SanghaCorporate Development Advisor & Director | 186,00k | 12,05k | Achat | 0,06 - 0,07 | 21,15M | 0,89% |
| 2025-07-28 | Dr. Stephen SanghaCorporate Development Advisor & Director | 10,00k | 692,55 | Achat | 0,07 | 20,97M | 0,05% |
| 2025-07-28 | Dr. Stephen SanghaCorporate Development Advisor & Director | 10,00k | 656,10 | Achat | 0,07 | 20,96M | 0,05% |
| 2025-07-22 | Dr. Stephen SanghaCorporate Development Advisor & Director | 20,00k | 1,32k | Achat | 0,07 | 20,95M | 0,10% |
| 2025-07-21 | Dr. Stephen SanghaCorporate Development Advisor & Director | 29,00k | 2,01k | Achat | 0,07 | 20,93M | 0,14% |
| 2025-07-17 | Dr. Stephen SanghaCorporate Development Advisor & Director | 700,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1 000,00k | 233,33% |
| 2025-07-14 | Dr. Stephen SanghaCorporate Development Advisor & Director | 51,00k | 3,68k | Achat | 0,07 | 20,90M | 0,24% |
| 2025-07-10 | Dr. Stephen SanghaCorporate Development Advisor & Director | 51,00k | 3,54k | Achat | 0,07 | 20,85M | 0,25% |
| 2025-07-04 | Dr. Stephen SanghaCorporate Development Advisor & Director | 20,00k | 1,32k | Achat | 0,07 | 20,79M | 0,10% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
